|
| Press Releases |
|
 |
|
| Friday, March 4, 2022 |
|
|
Altamira Therapeutics 與 Nuance Pharma 優銳醫藥簽署獨家協議，在中國及部分亞洲市場共同開發和商業化Bentrio(TM) 鼻噴劑 |
| Altamira Therapeutics Ltd. (NASDAQ: CYTO) (簡稱“Altamira”)，一家基於RNA療法、過敏原和病毒防護、內耳療法，致力於解決未被滿足的醫療需求的專業製藥公司，和Nuance Pharma Ltd. (簡稱“Nuance優銳”)今天宣布簽署一項獨家協議，在中國大陸、香港、澳門及韓國合作開發和商業化Bentrio(TM)，一種用於防護空氣中的過敏源和病毒的鼻噴劑。 more info >> |
|
|
Altamira Therapeutics 与 Nuance Pharma 优锐医药签署独家协议，在中国及部分亚洲市场共同开发和商业化Bentrio(TM) 鼻喷剂 |
| more info >> |
|
|
Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets |
| Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, announced today that it has entered into an exclusive licensing and distribution agreement (the "Agreement") for Bentrio(TM), its nasal spray for protection against airborne viruses and allergens, with Nuance Pharma Ltd. ("Nuance") in Chinese Mainland, Hong Kong, Macau and South Korea (the "Territory"). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 6, 2026 14:03 HKT/SGT
|
|
|
「工業數智化引擎」卡奧斯衝擊港交所 激活製造業新动能
Feb 6, 2026 12:45 HKT/SGT
|
|
|
「工业数智化引擎」卡奥斯冲击港交所 激活制造业新动能
Feb 6, 2026 12:38 HKT/SGT
|
|
|
Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market
Feb 6, 2026 12:21 HKT/SGT
|
|
|
穎通控股與連卡佛攜手打造首個頂級小眾香水殿堂 進一步拓展高毛利小眾香氛市場版圖
Feb 6, 2026 12:07 HKT/SGT
|
|
|
颖通控股与连卡佛携手打造首个顶级小众香水殿堂 进一步拓展高毛利小众香氛市场版图
Feb 6, 2026 11:53 HKT/SGT
|
|
|
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors
Feb 6, 2026 11:44 HKT/SGT
|
|
|
中國再保召開2026年黨建和經營管理工作會議
Feb 6, 2026 11:04 HKT/SGT
|
|
|
2月24日-2月27日、世界の金融リーダーが集結する国際フォーラム「GFTN Forum Japan 2026」開催
Feb 6, 2026 11:00: JST
|
|
|
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
Feb 6, 2026 11:31 JST
|
|
|
Muyuan Foods Makes Hong Kong Debut Today: Strong Cornerstone Investor Backing Fuels Rapid Earnings Growth, Embarking on New Journey of Internationalization
Feb 6, 2026 10:20 HKT/SGT
|
|
|
Fujitsu Japan and JMDC announce collaboration to build sustainable healthcare system in Japan through enhanced medical data utilization
Feb 6, 2026 11:14 JST
|
|
|
Genesys and Fujitsu Transform AEON Financial Service's Contact Center Operations with Genesys Cloud Delivers Customers an Improved Self-Service Experience Resulting in Higher Completion and Reduced Wait Times
Feb 6, 2026 10:44 JST
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 09:41 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL TECHNOLOGIES establishes total solutions system for contract manufacturing of various test kits including in vitro diagnostics
Feb 5, 2026 22:00 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
